Other Issues

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today following the U.S. House of Representatives passing H.R. 2269, the Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act:

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) released the following statement today after submitting comments to the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) regarding its Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients:

CHPA believes FDA should continuously evaluate food colors for safety using a transparent science-based approach. Policy changes should be science based and realistic about implementation timelines and the complex manufacturing realities involved.

(WASHINGTON, DC) – The Consumer Healthcare Products Association’s (CHPA) Health In Hand Foundation today announced its call for nominations for the 2025 U.S. Self-Care Marketing Awards. Winners will be announced at the 10th annual Health In Hand Foundation Gala on Nov. 12 at The Bellevue Hotel in Philadelphia.

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) today responded to an announcement from the Department of Commerce this week regarding the initiation of a Section 232 investigation into the national security implications of pharmaceutical imports, including finished drug products, active pharmaceutical ingredients (APIs), and other critical materials: